Marko Topalović, PhD is CEO and co-founder of ArtiQ (Leuven, Belgium). Marko was born and raised in Belgrade (Serbia). In 2012, he came to Belgium on a quest to acquire more knowledge and obtain a PhD degree.
Before co-founding ArtiQ, as a postdoctoral researcher at University Hospitals Leuven, Marko worked on improving and developing machine learning algorithms for the diagnosis of lung diseases. Marko obtained a his doctoral degree with a thesis on the topic “Artificial intelligence for pulmonary function tests” at the Laboratory for Respiratory Disease of the prestigious KU Leuven (university). With an MSc in Computer Sciences (University of Belgrade, Serbia), he continually tries to connect two fields, with the goal of augmenting healthcare using state-of-the-art technology. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Moreover, he received international awards on several occasions. Marko earned his business education from the Flanders Business School (Belgium).
Marko at a glance
Length of time in the Leuven Region: 7+ years
Reason for coming to Leuven: PhD studies
Favorite spot in Leuven: Arenberg Park
Favorite phrase in Dutch: Verschrikkelijk ('terrible') because it sounds so funny when you pronounce it. Second place is: Pintje ('beer')
ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). The company was founded early 2019 by four committed founders with an extensive history in respiratory medicine, medical devices, and artificial intelligence.
From their multidisciplinary backgrounds and five years of research, the founders identified the value that novel technologies could bring to all parties in the respiratory world: patients, doctors, healthcare systems, and the industry. ArtiQ aims to support doctors in the diagnosis, treatment, and follow-up of respiratory diseases.
With their first artificial intelligence-based software, ArtiQ.PFT, they support the interpretation of pulmonary function tests to improving the diagnostic environment for lung diseases. The software has been validated elaborately at UZ Leuven, where the software is used to create a report for every patient and has been used for close to 40.000 patients since the implementation in February 2018.
For more information, please visit their website.
Want to know more about what you saw in Marko's video or have read about here? Check out these links